Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 298, Issue 1, 2010, Pages

  Vockeroth, Dan ^a   Gunasekara, Lasantha ^b   Amrein, Matthias ^b   Possmayer, Fred ^a   Lewis, James F ^a   Veldhuizen, Ruud A W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Mechanical ventilation; Surface tension

Indexed keywords

CHOLESTEROL; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; LUNG INJURY; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; SURFACE TENSION; TIDAL VOLUME;

ADSORPTION; ANIMALS; BIOPHYSICAL PHENOMENA; CHOLESTEROL; MALE; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE TENSION; VENTILATOR-INDUCED LUNG INJURY;

EID: 73549108924     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00218.2009     Document Type: Article

References (43)

1. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, Suter PM. The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Am J Respir Crit Care Med 157: 1332-1347, 1998.
2. Bailey TC, Maruscak AA, Martin EL, Forbes AR, Petersen A, Mc-Caig LA, Yao LJ, Lewis JF, Veldhuizen RA. The effects of long-term conventional mechanical ventilation on the lungs of adult rats. Crit Care Med 36: 2381-2387, 2008.
3. Bernardino de la Serna J, Perez-Gil J, Simonsen AC, Bagatolli LA. Cholesterol rules: direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. J Biol Chem 279: 40715-40722, 2004.
4. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
5. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342: 1301-1308, 2000.
6. Cockshutt AM, Weitz J, Possmayer F. Pulmonary surfactant- associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29: 8424-8429, 1990.
7. Davidson KG, Acton SM, Barr HA, Nicholas TE. Effect of lowering serum cholesterol on the composition of surfactant in adult rat lung. Am J Physiol Lung Cell Mol Physiol 272: L106-L114, 1997.
8. Diemel RV, Snel MM, Van Golde LM, Putz G, Haagsman HP, Batenburg JJ. Effects of cholesterol on surface activity and surface topography of spread surfactant films. Biochemistry 41: 15007-15016, 2002.
9. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 157: 294-323, 1998.
10. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14: 492-497, 1979.
11. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408: 79-89, 1998.
12. Gunasekara L, Schoel WM, Schurch S, Amrein MW. A comparative study of mechanisms of surfactant inhibition. Biochim Biophys Acta 1778: 433-444, 2008.
13. Gunasekara L, Schurch S, Schoel WM, Nag K, Leonenko Z, Haufs M, Amrein M. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim Biophys Acta 1737: 27-35, 2005.
14. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
15. Guthmann F, Harrach-Ruprecht B, Looman AC, Stevens PA, Robenek H, Rustow B. Interaction of lipoproteins with type II pneumocytes in vitro: morphological studies, uptake kinetics and secretion rate of cholesterol. Eur J Cell Biol 74: 197-207, 1997.
16. Hass MA, Longmore WJ. Surfactant cholesterol metabolism of the isolated perfused rat lung. Biochim Biophys Acta 573: 166-174, 1979.
17. Holm BA, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49: 49-55, 1988.
18. Keating E, Rahman L, Francis J, Petersen A, Possmayer F, Veldhuizen R, Petersen NO. Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant. Biophys J 93: 1391-1401, 2007.
19. Leonenko Z, Finot E, Vassiliev V, Amrein M. Effect of cholesterol on the physical properties of pulmonary surfactant films: atomic force measurements study. Ultramicroscopy 106: 687-694, 2006.
20. Leonenko Z, Gill S, Baoukina S, Monticelli L, Doehner J, Gunasekara L, Felderer F, Rodenstein M, Eng LM, Amrein M. An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film. Biophys J 93: 674-683, 2007.
21. Malloy J, McCaig L, Veldhuizen R, Yao LJ, Joseph M, Whitsett J, Lewis J. Alterations of the endogenous surfactant system in septic adult rats. Am J Respir Crit Care Med 156: 617-623, 1997.
22. Markart P, Ruppert C, Wygrecka M, Colaris T, Dahal B, Walmrath D, Harbach H, Wilhelm J, Seeger W, Schmidt R, Guenther A. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Thorax 62: 588-594, 2007.
23. Maruscak AA, Vockeroth DW, Girardi B, Sheikh T, Possmayer F, Lewis JF, Veldhuizen RA. Alterations to surfactant precede physiological deterioration during high tidal volume ventilation. Am J Physiol Lung Cell Mol Physiol 294: L974-L983, 2008.
24. McCrae KC, Weltman B, Alyward S, Shaw RA, Sowa MG, Unruh HW, Rand TG, Thliveris JA, Scott JE. The effect of elevated dietary cholesterol on pulmonary surfactant function in adolescent mice. Pediatr Pulmonol 43: 426-434, 2008.
25. Mehta S, Slutsky AS. Mechanical ventilation in acute respiratory distress syndrome: evolving concepts. Monaldi Arch Chest Dis 53: 647-653, 1998.
26. Muscedere JG, Mullen JBM, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 149: 1327-1334, 1994.
27. Nitta K, Kobayashi T. Impairment of surfactant activity and ventilation by proteins in lung edema fluid. Respir Physiol 95: 43-51, 1994.
28. Ohvo H, Slotte JP. Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate. Biochemistry 35: 8018-8024, 1996.
29. Sankaram MB, Thompson TE. Cholesterol-induced fluid-phase immiscibility in membranes. Proc Natl Acad Sci USA 88: 8686-8690, 1991.
30. Schief WR, Antia M, Discher BM, Hall SB, Vogel V. Liquid-crystalline collapse of pulmonary surfactant monolayers. Biophys J 84: 3792-3806, 2003.
31. Schurch S, Bachofen H, Goerke J, Possmayer F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol 67: 2389-2396, 1989.
32. Seeger W, Stohr G, Wolf HR, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58: 326-338, 1985.
33. Suzuki Y. Effect of protein, cholesterol, and phosphatidylglycerol on the surface activity of the lipid-protein complex reconstituted from pig pulmonary surfactant. J Lipid Res 23: 62-69, 1982.
34. Van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system. News Physiol Sci 9: 13-20, 1994.
35. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 152: 1867-1871, 1995.
36. Veldhuizen RA, Welk B, Harbottle R, Hearn S, Nag K, Petersen N, Possmayer F. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. J Appl Physiol 92: 1169-1175, 2002.
37. Verbrugge SJ, Lachmann B. Mechanisms of ventilation-induced lung injury: physiological rationale to prevent it. Monaldi Arch Chest Dis 54: 22-37, 1999.
38. Verbrugge SJ, Sorm V, Lachmann B. Mechanisms of acute respiratory distress syndrome: role of surfactant changes and mechanical ventilation. J Physiol Pharmacol 48: 537-557, 1997.
39. Verbrugge SJ, Vazquez dA, Gommers D, Neggers SJ, Sorm V, Bohm SH, Lachmann B. Exogenous surfactant preserves lung function and reduces alveolar evans blue dye influx in a rat model of ventilationinduced lung injury. Anesthesiology 89: 467-474, 1998.
40. Yamashita C, Forbes A, Tessolini JM, Yao LJ, Lewis JF, Veldhuizen RA. Protective effects of elevated endogenous surfactant pools to injurious mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 294: L724-L732, 2008.
41. Yu SH, Possmayer F. Effect of pulmonary surfactant protein A (SP-A) and calcium on the adsorption of cholesterol and film stability. Biochim Biophys Acta 1211: 350-358, 1994.
42. Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324, 2007.
43. Zuo YY, Veldhuizen RA, Neumann AW, Petersen NO, Possmayer F. Current perspectives in pulmonary surfactant - inhibition, enhancement and evaluation. Biochim Biophys Acta 1778: 1947-1977, 2008.